EyePoint Pharmaceuticals

EYPT · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 27 days ago

Total Revenue

$620K

Previous year: $11.6M

-94.6%

EPS

-$0.81

Previous year: -$0.64

+26.6%

Research and Development

$59.2M

Previous year: $43.4M

+36.5%

Total Operating Expenses

$71M

Previous year: $56.8M

Previous year: $10.8M

-97.7%

Cash and Equivalents

$102M

Previous year: $99.7M

Loading...

EyePoint Pharmaceuticals

Unlock previous datapoints

Upgrade

EyePoint Pharmaceuticals

Unlock previous datapoints

Upgrade

EyePoint Pharmaceuticals Revenue by Segment

Revenue by Segment

Product sales, net Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

License and Royalties Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.04B

P/E Ratio

-4.73

Sector

N/A

Industry

N/A

52-Week High

$18.8

52-Week Low

$4.11

Research and Development

$59.2M

Total Operating Expenses

$71M

Sales and Marketing

-$6K

General and Administrative

$11.4M

Marketable Securities

$204M

Products

Get in Touch

Resources

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Revenue by Segment

Revenue by Segment

Product sales, net Revenue

License and Royalties Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics